12/10/2024China Biopharma CDMOs Win Reprieve as Biosecure Act Omitted from US De...

12/10/2024Beijing Hanmi Launches $98.65M Expansion Project Near Capital Airport

12/10/2024China Biopharma Tracker – November 2024 (PharmaDJ)

12/10/2024How Wholly Foreign-Owned Hospitals Can Help China's Health Care Sector...

12/10/2024The New Draft Administrative Measures For Management Of Medical Repres...

12/9/2024Belief Biomed Unveils Promising Gene Therapy Data at ASH 2024

12/6/2024Medical Costs in Mainland China and Hong Kong to Grow More Slowly Than...

12/6/2024CDE Seeks Comments on Draft ICH Guidelines M15

12/6/2024Recent Executive Moves

12/5/2024SK Biopharm Advances Epilepsy Treatment in China with NDA Submission ...

12/5/20242025 Trends Buoying Boom Phase in APAC (Biospectrum)

12/5/2024Big Pharma Doubles Down on China (The Wire China)

12/3/2024Big Pharma's Bet on China Biotech Is a Rare Trade Bright Spot (Bloomb...

12/3/2024CMS Gains Licenses Class 1 New Drug Targeting Gout and Hyperuricemia f...

12/3/2024Sanofi Allocates €1 Billion for New Insulin Manufacturing Facility in...

12/3/2024NHC Minister Meets with Sanofi and BioMérieux Bosses to Strengthen Si...

12/3/2024PharmaMar/Luye's Lurbinectedin Gains Approval in China for Treating Me...

12/3/2024NH DB6: Global and Chinese Consumer Healthcare Market: MAT Q2/2024 Tr...

12/3/2024HUTCHMED and Innovent's ELUNATE and TYVYT Combo Win Chinese Condi...

12/2/2024Everest Medicines Announces Acceptance of VELSIPITY NDA in Hong Kong

12/2/2024Hua Medicine Announces Successful H.K. SENSITIZE Study Results at the ...

12/2/2024Miracogen to Present Phase II Data on MRG003 at ESMO Asia 2024  

12/2/2024Zambon's Xadago (Safinamide) Gains Chinese Approval for Parkinson's Di...

12/2/2024Minghui Pharma Reports Positive Phase III Results for MH004 in Atopic ...

12/2/2024Merck's Recarbrio Approved in China for Severe Bacterial Pneumonia

12/2/2024UCB Closes Divestment from Neurology and Allergy Portfolio in China, ...

11/29/2024Recent Executive Moves

11/28/2024NHSA Issues Guidelines for Managing Pricing Risks of Shortage Drugs

11/28/2024NHSA and MOHRSS Announce the 2024 National Drug Reimbursement List

11/28/2024NMPA Solicits Public Comments on the Provisions for the Record Filing ...

Page:28/370 Total number of articles:11093: [First][<<] [26] [27] [28] [29] [30] [>>] [End]